Background: This study aims to understand the incidence and presence of lupus anticoagulant (LA) in children with recurrent upper respiratory tract infection (URTI). Methods: One hundred and sixty-five patients who were admitted to Departments of Pediatrics and Otolaryngology at Ege University Faculty of Medicine during the last 2 years and 120 age-matched healthy children as a control group were enrolled in the study. Results: The presence of LA in serum was positive in 8 (4.8%) cases in the patient group while only 2 (1.6%) cases in the healthy control group (P ¼ .03). Mean age of patients with LA positive was significantly lower than those of negative cases (P ¼ .02). Of the patients, 92 (55.8%) had adenoid hypertrophy. The annual frequency of URTI did not differ significantly between the LA patients and the LA-negative patients (7.5/year and 6.9/year, respectively). None of the patients with LA positive had adenoid hypertrophy (P ¼ .009). Activated partial thromboplastin time was prolonged in 6 (3.6%) of 165 patients. Of these 6 patients, 2 were also LA positive. The presence of LA disappeared in all the 8 patients 2 months after the diagnosis. Lupus anticoagulant was found negative in all patients at the end of the second month. Conclusion: We found that the ratio of the presence of LA is higher in children with recurrent URTI than healthy children. However, the presence of LA does not lead to bleeding and/or thrombosis, and it disappears in a short period of time.
Introduction
Antiphospholipid antibodies (APA) constitute a diverse group of autoantibodies reacting with phospholipids antigens. This group includes lupus anticoagulant (LA) and anticardiolipin antibodies. Antiphospholipid antibodies may be associated with systemic lupus erythematosus, other autoimmune disorders, connective tissue disorders, malignancies, drug use, and infections or with no underlying disease. [1] [2] [3] [4] Lupus anticoagulant, one of the major APA, is a member of a heterogeneous group of antibodies reacting with phospholipid protein complexes and can arise after events triggering the immune system. 5, 6 These APA have been found to be associated with many infections, although the pathogenic role for these antibodies is still unknown. [1] [2] [3] [4] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] The presence of LA is an important cause for delayed activated partial thromboplastin time (aPTT) test in children. In children, the presence of LA is usually transient, without causing any damage. However, children may rarely develop complications such as stroke, and it does not increase the risk of bleeding. Diagnosis of LA in asymptomatic children is usually incidental. It is generally determined when aPTT test is delayed after an upper respiratory tract infection (URTI) or during screening tests before surgical intervention. The presence of this antibody is usually temporary and is not correlated with clinical status. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] We studied the presence of LA in children with URTI to determine whether it was transient and tried to understand the incidence and clinical importance of LA in this patient group.
Patients and Methods Patients
One hundred and sixty-five patients who were admitted to Departments of Pediatrics and Otolaryngology at Ege University Faculty of Medicine during the last 2 years for an acute URTI were included in this study. The following data were obtained: patient's initials, medical identification (ID) number, date of birth, age, significant medical history or known diseases, and personal and family history for bleeding tendencies or known coagulopathy disorders. The patients who had a positive family history for bleeding tendencies, cancer, autoimmune diseases, thromboembolic conditions such as mechanical heart valve prostheses, central venous line, or implantable catheter were excluded from the study.
As the diagnostic criteria of recurrent URTI, patients who had acute tonsillitis, adenoiditis, sunisitis, or otitis media 7 times in the same year, 5 times a year for the consequent two years, or 3 times a year for 3 years in a row were included in the study. The first blood samples were obtained during the acute infection from patients for whom an operation had been planned due to chronic tonsillar and/or adenoid hypertrophy by the ear, nose, and throat specialist. Throat culture specimens were obtained from every patient, and reproduction of group A b hemolytic streptococcus was defined as bacterial infection. The study was approved by the Ethics Committee of medical faculty.
Methods
Lupus anticoagulant positivity was searched using a different test to achieve the highest sensitivity according to the suggestions of the THCC committee 5, 6 in Sigma Amelung AMAX-2000 coagulameter device using aPTT mixing test and the diluted Russell viper venom test (dRVVT) procedure (Accuclot dRVVT Screen and Accuclot dRVVT Confirm kits). The control group was formed by 120 healthy children of the same age by the LA confirmation test.
The patients who had high aPTT and positive LA, in other words, those who displayed a positive LA, underwent serum mixing test, and in this way, the sensitivity of these 2 tests were compared. Furthermore, patients who had a positive LA underwent a control for LA 2 months later. Patients were in good health at the time of the follow-up LA determination.
Obtaining Patient's Plasma and its Storage 1. Venous blood samples were used. A total of 8 mL of blood were placed into plastic tubes containing 1/9 citrate. The procedure was performed in fresh blood in the first half an hour. 2. To decrease the number of platelets in the patients, the blood was centrifuged at a rate of 3500 period/min (1500g) for 10 minutes. The aPTT test was performed on the obtained plasma the same day after centrifugation. 3. The remaining plasma was stored at À20 C to study the LA by dRVVT procedure for not more than 3 months. 4. Later on, these samples were dissolved at room temperature for LA confirmation and LA screen tests by the dRVVT procedure. Lupus anticoagulant positivity was searched using the screen/confirmation ratio.
Activated Partial Thromboplastin Time Test
The prepared 0.1 mL patient plasma was mixed with 0.1 aPTT reactive after having been centrifuged at 3500 period/min (1500g) for 10 minutes. This was incubated at 39 C for 3 minutes. The coagulation time was measured by the coagulometer device by addition of 0.1 mL 0.25 mol/L CaCL.
Preparation of the Plasma Pool Void of Platelets
A total of !4 mL of blood was obtained and transferred into citrated blue-colored lidded tubes from each of the 10 male and 10 females who were healthy, void of risk factors for thrombosis, and who had normal aPTT levels. To obtain plasma void of platelets, the blood was centrifuged at a rate of 3500 period/ minute (1500g) for 10 minutes. These plasma samples were mixed at þ4 C, and a plasma pool was prepared. The aPTT level of this pool was measured again. A sample was taken from the pool for the mixing procedure. The aPTT of the pool that had been prepared in our study was measured to be 28 seconds (normal range 28-40 seconds).
Mixing Procedure
Plasma samples of 0.5 mL were obtained from the patients who had high aPTT levels and normal plasma that was void of platelets (plasma pool; mixing ratio was 1:1), and the aPTT test was measured by the same method.
Lupus Anticoagulant Screen Test and LA Confirmation Test
Thirty-eight microliters of plasma was incubated for 60 seconds at 37 C, and the test was begun by the addition of 38 mL of dRVV test material. Coagulation time was determined by the device. The time passed in this period was the value for the ''LA screen'' in seconds.
Detection of LA Positivity
The cases in which the ratio of LA screen/LA confirmation value was !1.5 were considered LA positive. 
Results
Of 165 patients, 77 were female and 88 were male. Median age of the patients was 5.0 years with a range of 1.5 and 11 years. One hundred and twenty healthy children (60 female, 60 male; with an age group between 2 years and 10 years, mean age: 5.5 years) were enrolled as a control group.
The presence of LA in serum was positive in 8 (4.8%) cases in the patient group while only 2 (1.6%) cases in the healthy control group (P ¼ .03; Table 1 ). Mean age of patients with LA positive was significantly lower than those of negative cases (P ¼ .02). Of the patients, 92 (55.8%) had adenoid hypertrophy. None of the patients with LA positive had adenoid hypertrophy (P ¼ .009). Our cases were thought to have more bacterial infections with a positive culture than viral infections. Activated partial thromboplastin time was prolonged in 6 (3.6%) of 165 patients. Of these 6 patients, 2 were also LA positive. The presence of LA disappeared in all the 7 patients 2 months after the diagnosis. One patient did not come to follow-ups. Lupus anticoagulant was found negative in all patients at the end of the second month.
Discussion
To the best of our knowledge, this is the first study presenting the incidence and clinical importance of LA in Turkish children with recurrent URTI. There are 2 major types of LA in children. The first one, called ''post-infectious LA'' or type 1, is often seen in young children rather than adults, is generally asymptomatic, benign, and transient. This condition may cause bleeding due to hypoprothrombinemia in some children. The second type, called ''autoimmune LA'' or type 2, is seen in adolescents and adults and is more persistent and associated with thromboembolic events. 7, 8 We found that the ratio of the presence of LA was 4.8% in the patient group. Because LA positivity disappeared during follow-up, we thought that LA was of type 1 in our patients.
Pediatric patients with LA are usually girls and adolescents. Most LAs occurring in children are transient and believed to be associated with viral or bacterial infections. 7, 8 Lupus anticoagulant may be found incidentally in children at routine screening tests prior to surgery. Transient LA either reflects low disease activity or represents postinfectious antibodies and is frequently not associated with a thromboembolic event. Particularly in children, frequent infections may trigger transient LA that rarely lead to clinical complications. There were no complications in our patients during follow-up. Lupus anticoagulant was found negative in all patients (control and study) at the end of the second month. This ratio was similar to ratios recorded in the literature. [7] [8] [9] [10] [11] [12] [13] [14] [15] We have also investigated the role of infection frequency on the positivity of LA. The annual frequency of URTI did not differ significantly between the LA patients and the LA-negative patients (7.5/year and 6.9/year, respectively). However, the frequency of URTIs was 2/year. However, we could not find any data concerning frequency of infection and LA positivity in the literature.
Hemorrhagic LA syndrome is a rare entity, and it may occur in acquired thrombocytopenia or hypoprothrombinemia. [10] [11] [12] Thrombocytopenia was not observed in our LA-positive cases. Additionally, there were no thrombotic complications, bleeding events, or deaths in the patients group.
Although it was stated in the literature that LA positivity occurred mostly in female and young children, 7 we did not find any significant relationship of LA positivity with sex. However, the mean age of patients with LA positivity was significantly lower than patients with negative LA (P ¼ .02). The reason for this can be explained by the increased frequency of infections in the early childhood period.
Lupus anticoagulant is generally presented during viral infections including adenovirus, 4, 13 Parvo B19, 4, 14 Epstein-Barr virus (EBV), 4,15 cytomegalovirus (CMV), 4, 16 and varicella. 17, 18 Our cases were thought to have bacterial infections with a positive culture (25%) more than viral infections. In our study, while 55.8% of the patients had adenoid hypertrophy, the LA-positive patients had no adenoid hypertrophy (P ¼ .009). We thought that those patients had acquired LA secondary to a transient bacterial disease.
Becton and Stine 12 reported 6 cases of previously healthy children with clinical signs of bleeding and prolonged aPTT resulting from positive mixing studies and evidence of phospholipids dependence of the antibodies. In all cases, signs of bleeding resolved spontaneously within 3 months and laboratory findings returned to normal within 6 months. In our study, in cases with positive LA, laboratory findings returned to 9 In the study of Male et al, 7 it was found that the vast majority of the children had LA positivity in the screening before adeno-tonsillectomy and it was found out that these children had recurrent sinusitis, tonsillitis, and URTI previously. Tests for sensitivity containing minimal phospholipids and tests for specificity containing high degree of phospholipids or combined tests containing platelets have been suggested by some investigators for the search for LA. It has also been mentioned that plasma, the platelets of which have been deprived, would increase the sensitivity of the test. For this reason, we used aPTT, mixing, and dRVV tests together (2 tests for screening and confirmation) to increase the sensitivity of LA determination in our study. We tried to reach a better diagnosis by performing not only the LA screen test but the LA screening test and confirmation tests together. We found low specificity but high sensitivity for the aPTT test in our study. Sensitivity was 25% and specificity was 97% ( Table 2) . These values were concordant with those of the literature. [7] [8] [9] [10] [11] [12] Our results show that the sensitivity of the aPTT test for revealing LA positivity is low while its specificity is high ( Table  2) . In this condition, as seen in our study, it can be concluded that aPTT is insufficient to determine weak inhibitors and its sensitivity is low. The aPTT is invariably prolonged in patients with the LA and is considered the most sensitive screening test. The important point here is the unnecessary investigations that are performed on patients who have high aPTT levels prior to the operation, unnecessarily increasing the costs. We recommend that LA screen and LA confirmation tests should definitely be performed beside aPTT when there is a suspicion of the presence of LA. However, should the aPTT test turn out to be normal, LA test should be performed when there is a suspicion.
Our study had some limitations. It would be better if we had studied anticardiolipin and anti-b2GP1 antibodies beside the LA antibodies. Furthermore, more effective results would have been obtained if we had investigated the other causes resulting in thrombosis and factors leading to bleeding.
In conclusion, the incidence of LA positivity was higher in young children with recurrent URTI than healthy children. However, LA positivity does not lead to bleeding and/or thrombosis, and it disappears in a short period of time. It is clear that patients who have LA positivity causing delayed aPTT can be operated without any bleeding problem. Specific therapy is usually not needed. Further prospective multicenter studies are required to understand clinical outcomes and laboratory correlation in children with positive LA. NOTES: aPPT ¼ activated partial thromboplastin time; LA ¼ lupus anticoagulant; negative predictive value ¼ 0.96 (95% confidence interval ¼ 0.84-1.00); positive predictive value ¼ 0.33 (95% confidence interval ¼ 0.20-0.60); sensitivity ¼ 0.25 (95% confidence interval ¼ 0.0-0.50); specificity ¼ 0.97 (95% confidence interval ¼ 0.85-1.00).
